Annual prizes from a Canadian foundation recognize the most significant advances in human biology and medicine ...

CNW/ - The Gairdner Foundation today announced the nine 2026 Canada Gairdner Award laureates, honouring world-leading ...

Rare years in the history of any state are simple and cloudless. Time brings its challenges and difficulties that must be ...

BioVersys strengthens its Ansamycin Chemistry platform and research on tackling difficult-to-treat non-tuberculous mycobacteria (NTM) diseases.

A growing body of research is reframing endometriosis as far more than a pelvic condition. Scientists now have direct evidence that the disease, which affects about 10% of women of reproductive age, ...